Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party

Abstract Background Allogeneic hematopoietic stem cell transplantation (allo-SCT) is an established treatment for peripheral T-cell lymphoma (PTCL), particularly for patients with relapsed/refractory (r/r) disease. We aimed to retrieve novel information on the role of histology, disease status prior...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Evgenii Shumilov, Maud Ngoya, Philipp Berning, Raynier Devillier, Edouard Forcade, Thomas Schroeder, Frank Kroschinsky, Matthias Stelljes, Veronika Valkova, Francesca Kinsella, Patrice Chevallier, Gitte Olesen, Mohamad Mohty, Flore Sicre de Fontbrune, Eva Wagner-Drouet, Robert Zeiser, Marco Herling, Georg-Nikolaus Franke, Lucía López-Corral, Francis Ayuk, Georg Lenz, Gerald Wulf, Anna Sureda, Arain Laurence, Peter Dreger, Ali Bazarbachi, Norbert Schmitz
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2026-02-01
Sarja:	Journal of Hematology & Oncology
Aiheet:	PTCL NOS AITL ALK-negative ALCL Allogeneic stem cell transplantation EBMT
Linkit:	https://doi.org/10.1186/s13045-026-01783-w
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!